Average cost per visit for HIV and HTN care (absolute vs. relative contributions). by Drew B. Cameron (10687420)

Subjects:

Crude and stage-specific incidence rate of liver cancer per 100,000 over 2014–2023. by Ayana Ablayeva (22103708)

Subjects:

Reasons given by parents/guardians of incompletely vaccinated children (Zero-dose and one-dose OPV vaccination). by Zahid Hasan Khan (6281396)

Subjects:

Crude and age-specific mortality to incidence ratios of liver cancer per 100,000 over 2014–2023. by Ayana Ablayeva (22103708)

Subjects:

Determinants of incomplete vaccination. by Zahid Hasan Khan (6281396)

Subjects:

Gendered descriptive statistics for socioeconomic capital, insect knowledge, and perception. by Nancy Ndung’u (21601567)

Subjects:

Crude and residence-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023. by Ayana Ablayeva (22103708)

Subjects:

GLM models for predictors of monthly HTN care costs. by Drew B. Cameron (10687420)

Subjects:

A comparison of <i>E. coli</i> contamination at Traditional Lanna restaurants before and after the model’s implementation. by Vivat Keawdounglek (9710710)

Subjects:

Median monthly care costs, projected visits, and hospitalization costs. by Drew B. Cameron (10687420)

Subjects:

ESR estimates of the average treatment effect for female decision makers. by Nancy Ndung’u (21601567)

Subjects:

Characteristics of non-diarrheal stool samples from 1715 children in MAL-ED study. by Haley A. Liakakos (21445884)

Subjects:

Pure Ammonia-Fueled Roller Kiln for the Production of Ceramic Tiles: A First Demonstration by Jiwei Zhou (12059885)

Subjects:

A comparison of Paraquat contamination^a numbers and percentages in different concentrations (unit:ppm). by Vivat Keawdounglek (9710710)

Subjects:

Summary of the research methodologies. by Vivat Keawdounglek (9710710)

Subjects:

ESR estimates of the average treatment effect male decision makers. by Nancy Ndung’u (21601567)

Subjects:

Age- and sex- specific median yearly incidence (A) and mortality (B) rate of liver cancer per 10⁶ population over 2014–2023. by Ayana Ablayeva (22103708)

Subjects:

Distribution of background characteristics of the study participants (N = 18255). by Zahid Hasan Khan (6281396)

Subjects:

Regional and temporal burden of liver cancer in Kazakhstan (2014–2023). by Ayana Ablayeva (22103708)

Subjects:

5-HT- induced mitochondrial ROS inhibits <i>P</i>. <i>berghei</i> infection. by Li Gao (131516)

Subjects: